Alamar Biosciences ALMR Balance Sheet Statement
| Q1 '26 | Q4 '25 | ||
|---|---|---|---|
| $64.59M+115% | $30M— | ||
| $19.52M+53.1% | $12.75M+2,293% | ||
| $39.93M+3.8% | $38.48M+1,533% | ||
| $141.47M+49.4% | $94.71M— | ||
| $10.47M-0.2% | $10.5M— | ||
| $186.45M+33.2% | $139.99M— | ||
| $5.64M-4.0% | $5.87M+916% | ||
| $24.05M+1.3% | $23.73M— | ||
| $129.53M+103% | $63.95M— | ||
| -$190.1M-12.6% | -$168.78M— | ||
| -$178.07M-12.0% | -$158.95M— | ||
| $186.45M+33.2% | $139.99M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Alamar Biosciences 's total assets?
- Alamar Biosciences (ALMR) holds $186.5M in total assets.
- How much debt does Alamar Biosciences have?
- Alamar Biosciences carries $30.6M in total debt against -$178.1M of shareholders' equity, a debt-to-equity ratio of -0.17.
- How much cash does Alamar Biosciences have?
- Alamar Biosciences holds $64.6M in cash and equivalents.
- Can Alamar Biosciences cover its short-term obligations?
- Its current ratio is 5.88 — current assets exceed current liabilities.
- Where does Alamar Biosciences 's balance sheet data come from?
- Every line is extracted from Alamar Biosciences 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.